2023
Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research
Ebrahimi H, Castro D, Feng M, Prajapati S, Lee K, Chan E, Paul T, Sehgal I, Patel J, Li X, Zengin Z, Meza L, Mercier B, Hsu J, Govindarajan A, Chawla N, Dizman N, Bergerot C, Rock A, Liu S, Tripathi A, Dorff T, Pal S, Chehrazi-Raffle A. Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research. Clinical Genitourinary Cancer 2023, 21: e467-e473. PMID: 37301665, DOI: 10.1016/j.clgc.2023.05.013.Peer-Reviewed Original ResearchConceptsProstate cancer clinical trialsHBV/HCV infectionCancer clinical trialsHepatitis B virusClinical trialsConcurrent malignancyBrain metastasesEligibility criteriaHCV infectionHIV infectionExclusion criteriaClinical OncologyEastern Cooperative Oncology Group scaleAssessment of recommendationsECOG PS 0C virus infectionRestrictive eligibility criteriaAmerican SocietyCancer researchHCV positivityPS 0HIV positivityImmunotherapy trialsB virusVirus infection
2014
Mind the gap: Efficacy versus effectiveness and pivotal prostate cancer clinical trial demographics
Galsky M, Oh W. Mind the gap: Efficacy versus effectiveness and pivotal prostate cancer clinical trial demographics. Cancer 2014, 120: 2944-2945. PMID: 24965362, DOI: 10.1002/cncr.28808.Peer-Reviewed Original ResearchDistribution and geographic accessibility of prostate cancer clinical trials in the United States.
Galsky M, Latif A, Stensland K, Moshier E, McBride R, Hendricks R, Sonpavde G, Godbold J, Hall S, Oh W, Wisnivesky J. Distribution and geographic accessibility of prostate cancer clinical trials in the United States. Journal Of Clinical Oncology 2014, 32: 59-59. DOI: 10.1200/jco.2014.32.4_suppl.59.Peer-Reviewed Original ResearchAdvanced prostate cancerMetastatic prostate cancerProstate cancerClinical trial sitesProstate cancer clinical trialsClinical trialsTreatment of metastatic prostate cancerFirst-line therapyFirst-line treatmentProportion of patientsPopulation of patientsUS clinical trialsPCa patientsCancer clinical trialsPatientsTrial accrualEvaluate heterogeneityTrial accessTrial sitesTrialsUS populationCancerConsistent with prior studiesUnited StatesZip codes
2004
Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities
Murthy VH, Krumholz HM, Gross CP. Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities. JAMA 2004, 291: 2720-2726. PMID: 15187053, DOI: 10.1001/jama.291.22.2720.Peer-Reviewed Original ResearchConceptsCancer trialsCancer clinical trialsClinical trialsTrial participantsEnrollment fractionWhite patientsAge groupsCross-sectional population-based analysisProstate cancer clinical trialsCancer research participationCancer trial participantsColorectal cancer trialsPatients 75 yearsIncident cancer patientsLung cancer trialsPopulation-based analysisRelative risk ratiosAge-based disparitiesYears of ageNational Cancer InstituteLogistic regression modelsLittle recent informationTrial enrolleesYounger patientsPatient group
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply